Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/17/15  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Anthony J. Pinching

Wrong Prof. Anthony J. Pinching?


Theatrescience company

Employment History

  • Scientific Adviser
    Theatrescience company
  • Associate Dean for Cornwall, Professor of Clinical Immunology
    Peninsula Medical School
  • Clinical Immunologist and Associate Dean for Cornwall
    Peninsula Medical School
  • Chairman
    Investment Steering Group
  • Chairman
    CFS/ME Service Implementation Steering Group for the Centres
  • Deputy Chair of the Chief Marketing Officer
    Working Group
  • Chairman
    Department of Health on CFS/ME
  • Lead Adviser
    Department of Health on CFS/ME
  • Principal Medical Adviser
    AFME , Inc.
  • Medical Director
    AFME , Inc.
  • Professor
190 Total References
Web References
Theatrescience, 17 Mar 2015 [cached]
One of the playwrights at the workshop, Simon Turley, developed the play 'Seeing Without Light' (pictured), working with Professor Anthony Pinching from the Peninsula Medical School.
Subsequently Simon has become the Theatrescience resident writer and Tony the ongoing scientific advisor.
Professor Anthony J. Pinching, Scientific Adviser
Professor Pinching is Associate Dean for Cornwall, Professor of Clinical Immunology, at the Peninsula College of Medicine and Dentistry. He has previously held posts including Louis Freeman Professor of Immunology & Head of Division, Molecular Pathology, at Barts and The London/QMUL. and Honorary Fellow Department of Human Science and Medical Ethics, QMUL. He has published over 250 peer-reviewed papers and 5 books on HIV/AIDS, CFS/ME, and medical ethics, and has a strong interest in public policy involvement.
Comments on the NICE Draft Guideline by Margaret Williams on behalf of the 25% ME Group [cached]
Given the intimation mentioned above that there will be no major changes to the Draft Guideline, it is a matter of grave concern that on 16 th November 2005 Professor Anthony Pinching, Chair of the NHS "CFS/ME" Service Investment Steering Group, informed the All Party Parliamentary Group on ME that "Services will implement the NICE guidelines after these are announced in April 2007".
"Chairman and lead clinician for the programme is Professor Anthony Pinching, a clinical immunologist and Associate Dean for Cornwall at the Peninsula Medical School. He commented: 'The Programme is all about enablement - enabling patients, enabling carers, enabling healthcare professionals: each enabling each other. By creating a fresh, multi-professional and national collaborative team for CFS/ME patients, we now have a framework on which to base enhanced awareness and education' ".
"Chief Medical Officer Sir Liam Donaldson said: 'I am very grateful to the way in which Professor Pinching has led this programme. The Government's £8.5 million programme to improve services for people with chronic fatigue syndrome/ME has been a tremendous success and has fulfilled its aim to establish clinical networks of expertise. While 65% of the country now has a specialist CFS/ME service, we are keen that the rest of the country follows suit' ".
"Professor John Tooke, Dean of the Peninsula Medical School commented: 'The Peninsula Medical School is proud to have been the host for this important initiative and commends the achievement of Professor Pinching and his colleagues across England for developing services for such a disabling condition.
In the Press Release Professor Pinching refers to "CFS/ME" as a 'beastly illness', but the UK ME community knows that Pinching has a troubling track record in relation to ME/CFS in at least three significant areas:
· in 1989 the Royal College of Physicians agreed to produce a Report that was designed to discredit alternative and complementary medicine approaches to the treatment of allergies and hypersensitivities (which are commonly seen in ME/CFS). Pinching, then at Barts in London, was on the committee that produced this Report. By the autumn of 1991, the Report committee had produced a first draft (Allergy: Conventional and Alternative Concepts). A leading member of HealthWatch (the campaigning organisation to which both Simon Wessely and Charles Shepherd belong that is known for its anti-complementary medicine stance) illegally used the draft Report as evidence against a plaintiff in a High Court action even though on 18 th October 1991 solicitors for the Royal College of Physicians (Field Fisher Waterhouse) had written a letter forbidding use of the draft report, saying: "The College is not in a position to endorse the contents or conclusions of the draft". The draft Report that Pinching helped formulate was never released: it came under massive critical review and had to be re-written, as Fellows of the Royal College described it as "wildly inaccurate" and misleading. However, the Judge accepted the unauthorised draft, on the strength of which he found against the Plaintiff
· During his time as Deputy Chair of the Chief Medical Officer's Working Group, Pinching published an article that effectively pre-empted the conclusions of the CMO's Working Group Report, ie. that the treatment of choice for "CFS/ME" was to be CBT/GET. Pinching stated (i) that CFS was " not related to ongoing exertion" (ii) that the Oxford criteria were " too narrow" (the Oxford criteria being the case definition of "CFS" that expressly includes psychiatric fatigue but expressly excludes neurological disease); (iii) that " over-investigation can be counterproductive to the management of these patients, causing them to seek abnormal test results to validate their illness "; (iv) that "it is helpful to establish with the patient a way of thinking about the illness "; (v) that " the benefits of graded exercise have been shown by randomised controlled trials "; (vi) that "complementary therapists reinforce unhelpful illness beliefs " and (vii) "the essence of treatment is activity management and graded rehabilitation " (Chronic Fatigue Syndrome. Anthony J Pinching. Prescribers' Journal 2000:40:2:99-196)
· Also during his tenure of the Deputy Chairmanship of the CMO's Working Group Report, Pinching asserted --- in defiance of ever-increasing calls from international experts in ME/CFS for urgent sub-grouping of the heterogeneous label "CFS" - that there was no need for such sub-grouping, which he claimed was nothing more than "semantics" (see CMO's Report, Annex 4). For illustrations of the call by international experts for sub-grouping, see
Despite - or possibly because of - this track record, Pinching was appointed Chairman of the CFS/ME Service Implementation Steering Group for the new Centres, as well as being Lead Adviser on CFS/ME to the Department of Health.
In the NICE Draft Guideline, Pinching is singled out for special acknowledgement. To those of a sceptical disposition, this would appear to be history repeating itself, especially given Pinching's known preference for CBT/GET in "CFS". This prediction is supported not only by his confident prophecy in November 2005 to the All Party Parliamentary Group on ME concerning the implementation of the NICE Guideline, but also by his oral submission on 10 th July 2006 to the Gibson Parliamentary Inquiry on ME/CFS. From the notes taken by those who attended that session (and from their personal reports), Pinching openly and confidently said that he promotes the NICE Guideline and fully supports the biopsychosocial model and the implementation of CBT/GET. This confidence suggests prior knowledge of the outcome of the final Guideline. It was reported that Pinching also emphasised the need to make sure the new NHS services for "CFS/ME" continue to receive on-going funding, and said that the NICE Guideline (due in April 2007) would have an effect on how the Centres "manage" CFS/ME patients, ie. that the Centres would be needed to implement the NICE Guideline. It was reported that Pinching was very proud of the Centres and said that what was now needed was to extend and strengthen the current service by increasing patient through-put, which does not auger well for those with ME/CFS.
quotesonwhobenefits - The Hummingbirds' Foundation for M.E., 19 May 2014 [cached]
It is of interest that it is Professor Anthony Pinching who is AfME's Principal Medical Adviser.  Currently, AfME takes the view that as a charity, it should not raise money to fund research into M.E.  Quite certainly, AfME is not only supporting but is closely involved with the MRC psychiatric trials, as well as the new "Centres of excellence" that will deliver CBT and GET.  It is of note that it is Professor Pinching who is Chairman of the Investment Steering Group that devised the process and criteria for the setting up of these Centres and who allocated the funds.  Pinching is also lead adviser for the Department of Health on "CFS/ME".
A Hummingbirds Guide to M.E. - Information on the neurological disease Myalgic Encephalomyelitis [cached]
It may also be salutary to reflect on the opinion expressed by Professor Pinching (deputy Chair of the CMO's Working Group) in his article on CFS in Prescribers' Journal ie. that "over-investigation can (cause patients) to seek abnormal test results to validate their illness". (33) Prescribers' Journal was a publication of the UK Department of Health but is no longer produced.
Anthony J Pinching.Prescribers' Journal 2000:40:2: 99-106 Editorial: The Biology of the Chronic Fatigue Syndrome.
Medical Advisors | About Us - ME Support in Brighton, 20 May 2011 [cached]
Professor Anthony J Pinching
Professor Anthony Pinching
Professor Anthony J Pinching has since 2003 been Associate Dean for Cornwall, and Professor of Clinical Immunology, in the Peninsula Medical School, with his base at the Royal Cornwall Hospital, Truro. He trained in Medicine at Oxford, also gaining DPhil (in Neuroanatomy). After postgraduate training, he became Senior Lecturer, then Reader, in Clinical Immunology at St Mary's, and in 1992 took up the Louis Freedman Chair in Immunology at St Bartholomew's. His academic and clinical interests have included cellular immunology, autoimmunity (myasthenia gravis, vasculitis), immunodeficiency (especially HIV/AIDS), chronic fatigue syndrome (CFS/ME), and medical ethics. He was Deputy Chairman of CMO's CFS/ME Working Group, and was the Chairman of the Department of Health's CFS/ME Service Investment Steering Group. His clinical focus is now predominantly on CFS/ME.
Other People with the name "Pinching":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.